Otomycosis or fungal external otitis is a fungal infection of the external auditory
canal, typically caused by Aspergillus and Candida species. This review aims to
summarize current research on the effectiveness of clotrimazole in treating
otomycosis, comparing it with other antifungal treatments. Clotrimazole, an
azole antifungal, has a broad spectrum of action and is commonly used in
otomycosis therapy. The article evaluates its effectiveness against other treatment
methods, including other antifungal preparations. Additionally, it discusses the
etiology, epidemiology, and risk factors of otomycosis, providing a
comprehensive understanding of the condition and the most effective
pharmacological interventions. Clotrimazole demonstrates high efficacy against
yeasts and fungi causing otomycosis, surpassing other antifungal drugs.
Histological and physiological studies on animal models confirm their safety and
lack of ototoxic effects, and long-term use in clinical practice is considered safe.
Clotrimazole is a secure, affordable, and effective treatment option for
otomycosis of the external ear. It delivers the expected results and meets the
therapeutic needs of doctors and patients dealing with this condition, bringing
satisfaction with the treatment outcomes.
Keywords: Aspergillus, Clotrimazole, Otomycosis, External Otitis
